Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

This study has been completed.
Sponsor:
Information provided by:
Regional Hospital Holstebro
ClinicalTrials.gov Identifier:
NCT00438503
First received: February 20, 2007
Last updated: September 14, 2007
Last verified: September 2007

February 20, 2007
September 14, 2007
May 2006
Not Provided
Effect og glucose in dialysis water on blood pressure, plasma glucose and hormones in plasma
Same as current
Complete list of historical versions of study NCT00438503 on ClinicalTrials.gov Archive Site
Relationship between changes in blood pressure and and changes in hormones
Relationsship between changes in blood pressure and and changes in hormones
Not Provided
Not Provided
 
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
Effect of Glucose in Dialysis Water in Diabetics With Chronic Renal Failure on Blood Pressure, Pulse Rate, Plasma Glucose, Plasma Concentrations of Insulin, Growth Hormone, Renin, Angiotensin II, Endothelin and Body Temperature

The purposes are 1. to measure the effect of dialysis with glucose in dialysis water on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and 2. to analyse the relationship between the changes in blood pressure and changes in vasoactive hormones

The relationship between blood pressure during dialysis treatment and vasoactive hormones are studied. This includes measurements of plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Renal Failure, Chronic
  • Diabetic Nephropathies
Procedure: Procedure
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18
May 2007
Not Provided

Inclusion Criteria:

  1. Age > 18 years,
  2. Both men and women,
  3. Dialysis treatment for at least three month due to diabetic nephropathy

Exclusion Criteria:

  1. Heart failure,
  2. Lung insufficiency,
  3. Chronic liver disease,
  4. Malignant disease,
  5. Nephrotic syndrome,
  6. Lack of compliance,
  7. Unwillingness to participate
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00438503
MED.RES.2007.02.EBP
No
Not Provided
Regional Hospital Holstebro
Not Provided
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro
Regional Hospital Holstebro
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP